In the SURMOUNT-5 trial, which directly compared the two, Mounjaro produced a 20.2% weight loss, compared with 13.7% for semaglutide 2.4 mg over 72 weeks
For athletes subject to anti-doping regulations, semaglutide is not currently listed as a prohibited substance by the World Anti-Doping Agency (WADA)
Secondary Research With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects
When prescribing the medication, cardiologists follow specific guidelines, such as: Considering cardiovascular risk factors: These include hypertension, high cholesterol, Type 2 diabetes, and a family history of heart disease
Renowned for mimicking the GLP-1 hormone, semaglutide helps reduce appetite and enables significant weight loss while enhancing overall health
The decision should always be made together with a licensed medical provider who can explain your options, review your health history, and answer your questions based on up-to-date evidence